Awarded
Vacunas inactivadas producidas a partir de virus crecidos en huevos embrionados, de virus fraccionados o de antígenos de superficie (H y N), o análogas, de 15 microgramos de hemaglutinina de cada cepa incluida en la vacuna, con adyuvante o análogas.
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- SEQIRUS SPAIN S.L.
- Contract value
- €6,175,000
- Bids received
- 1
- Published
- 11 Sept 2026
- Awarded
- 10 Sept 2026
- Contract start
- 10 Sept 2026
- Contract end
- 11 Sept 2027estimated
- Region
- Valladolid